24434955

Martorell MR

2014

Chromosome 16 abnormalities in embryos and in sperm from a male with a fragile site at 16q22.1.

24435452

Liu Y

2014

Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

24435776

Lauritsen MP

2014

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.

24435777

Nordqvist S

2014

Sexual orientation of women does not affect outcome of fertility treatment with donated sperm.

24439532

Lee YH

2014

Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.

24442187

He H

2014

Unravelling the proteome of adult rhesus monkey ovaries.

24443957

Cho YH

2014

Puberty as an accelerator for diabetes complications.

24444560

Zhu RR

2013

[Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].

24445124

Palioura E

2013

Industrial endocrine disruptors and polycystic ovary syndrome.

24447981

Esmaeilzadeh S

2014

Polycystic ovary syndrome in Iranian adolescents.

24452876

Falhammar H

2014

Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?

24453507

Hendawy SF

2011

Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination.

24456922

G?mez-P?rez AM

2014

[Liraglutide in polycystic ovary syndrome].

24457404

Koiou E

2013

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome.

24458485

Lopes IM

2014

Histomorphometric Analysis and Markers of Endometrial Receptivity Embryonic Implantation in Women With Polycystic Ovary Syndrome During the Treatment With Progesterone.

24464003

Komarowska H

2013

Differences in the psychological and hormonal presentation of lean and obese patients with polycystic ovary syndrome.

24466303

Cai X

2014

Association between fat mass- and obesity-associated (FTO) gene polymorphism and polycystic ovary syndrome: a meta-analysis.

24471491

Aziz M

2014

Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40.

24472754

Tepav?evi? S

2014

Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome.

24479022

Fakhoury H

2012

Age and BMI Adjusted Comparison of Reproductive Hormones in PCOS.

24479991

Rodrigues AM

2015

Poor quality diet is associated with overweight status and obesity in patients with polycystic ovary syndrome.

24480115

Ferreira GD

2014

Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin.

24482740

Li X

2014

PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma.

24483039

Hern?ndez-Valencia M

2013

[Decreased insulin resistance with amino acids, extracts and antioxidants in patients with polycystic ovary syndrome].

24484553

Li YH

2013

[Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].

24484993

Grigorescu V

2014

Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction.

24485160

Chirico V

2014

LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.

24485279

Bruyneel A

2014

[Polycystic ovary syndrome: what are the obstetrical risks?].

24489477

Sanchez N

2014

A life course perspective on polycystic ovary syndrome.

24490508

Chen L

2013

[The value of different obese criteria for the assessment of insulin resistance in women with polycystic ovary syndrome].

24491161

Azziz R

2014

Polycystic ovary syndrome: what's in a name?

24491275

Brzana J

2014

Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary.

24491986

Ke RW

2014

Endocrine basis for recurrent pregnancy loss.

24494277

Li N

2013

[Efficacy and safety evaluation of acupuncture combined with auricular point sticking therapy in the treatment of polycystic ovary syndrome].

24496360

Velija-A?imi Z

2014

Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.

24497217

Yilmaz H

2014

Serum galectin-3 levels in women with PCOS.

24498077

Louwers YV

2014

BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study.

24498697

Roessler KK

2012

Supportive relationships--psychological effects of group counselling in women with polycystic ovary syndrome (PCOS).

24500511

Rehme MF

2013

[Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].

24501149

Unfer V

2014

Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS.

24502037

Stoian D

2013

Metabolic syndrome: its features in overweight women with polycystic ovary syndrome as compared with obese women without ovarian dysfunction?

24502610

Mirza SS

2014

Association between circulating adiponectin levels and polycystic ovarian syndrome.

24502891

Celik C

2014

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.

24505354

Sang Q

2014

Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome.

24505559

Lim KS

2013

In vitro maturation: Clinical applications.

24505565

Joob B

2013

Letter to the Editor: Serum anti-M?llerian hormone levels and phenotypes of polycystic ovary syndrome.

24505566

Kim HO

2013

The Author Response: Serum anti-M?llerian hormone levels and phenotypes of polycystic ovary syndrome.

24505633

Zhivkova R

2013

[Investigation of cytokeratin and vimentin intermediate filaments in polycystic ovaries (PCOS) -- presence and specific structure of Balbiani body in primordial follicles].

24505965

Jakimiuk AJ

2014

[The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders].

24512495

Roe A

2014

Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

24512496

Gonz?lez F

2014

Hyperandrogenism induces a proinflammatory TNF? response to glucose ingestion in a receptor-dependent fashion.

24513727

AlSerri A

2014

Lateralization of ovarian follicles.

24515540

Oleszczak B

2014

Transport of deoxy-D-glucose into lymphocytes of patients with polycystic ovary syndrome.

24516084

Kollmann M

2014

Terms and thresholds for the ultrasound evaluation of the ovaries in women with hyperandrogenic anovulation.

24516121

Sen A

2014

Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression.

24517075

Liu YH

2013

[Non-pharmacological therapy of obesity-type polycystic ovary syndrome].

24517280

Wang F

2014

Differential genes in adipocytes induced from polycystic and non-polycystic ovary syndrome-derived human embryonic stem cells.

24517721

Kocer D

2014

The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome.

24519938

Yi T

2014

LGR4/GPR48 inactivation leads to aniridia-genitourinary anomalies-mental retardation syndrome defects.

24520081

Clark NM

2014

Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

24520086

Japur CC

2014

Imbalance Between Postprandial Ghrelin and Insulin Responses to an Ad Libitum Meal in Obese Women With Polycystic Ovary Syndrome.

24520334

Jang M

2014

Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.

24520442

Kao YH

2013

Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseases.

24520446

Figen Turkcapar A

2013

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization.

24520447

Pourteymour Fard Tabrizi F

2013

Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.

24520473

Bagheri M

2013

Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk.

24520500

Morotti E

2014

Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome.

24520503

Yildiz Y

2014

Serum adiponectin level and clinical, metabolic, and hormonal markers in patients with polycystic ovary syndrome.

24520755

Ibricevic D

2013

Frequency of prediabetes in women with polycystic ovary syndrome.

24522025

Grzechocinska B

2013

The role of vitamin D in impaired fertility treatment.

24522614

Alebi? M?

2014

Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.

24524197

Ortega I

2014

Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.

24524360

Guzel EC

2014

Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.

24526356

Seleem AK

2014

Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection.

24527662

Wang P

2014

Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.

24528623

Sahin SB

2014

Epicardial adipose tissue thickness and NGAL levels in women with polycystic ovary syndrome.

24530312

Kohan L

2014

Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk.

24532600

Tehrani FR

2014

Introducing a rat model of prenatal androgen-induced polycystic ovary syndrome in adulthood.

24533710

Schweighofer N

2014

Metformin resistance alleles in polycystic ovary syndrome: pattern and association with glucose metabolism.

24534277

Quinn M

2014

Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features.

24534278

Kollmann M

2014

Examining the ovaries by ultrasound for diagnosing hyperandrogenic anovulation: updating the threshold for newer machines.

24534279

Salameh WA

2014

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.

24534284

Lujan ME

2014

Reply of the authors.

24534285

Dinelli L

2014

Prognosis factors of pregnancy after intrauterine insemination with the husband's sperm: conclusions of an analysis of 2,019 cycles.

24534286

Tzeng CR

2014

Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age.

24546319

VIGNALOU J

1960

Amenorrheas of endocrine nature and celioscopy.

24548821

Ferri N

2014

Clinical evidence of statin therapy in non-dyslipidemic disorders.

24549213

Joham AE

2014

Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.

24549596

Kruszy?ska A

2014

Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment.

24551574

Dehdashtihaghighat S

2013

Assessment of C-reactive Protein and C3 as Inflammatory Markers of Insulin Resistance in Women with Polycystic Ovary Syndrome: A Case-Control Study.

24552422

Caserta D

2014

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.

24554292

Ovireddy S

2014

Speckle suppressing anisotropic diffusion filter for medical ultrasound images.

24554512

Dardzi?ska JA

2014

Effects of metformin or an oral contraceptive containing cyproterone acetate on serum c-reactive protein, interleukin-6 and soluble vascular cell adhesion molecule-1 concentrations in women with polycystic ovary syndrome.

24559619

Tartagni MV

2014

Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.

24559720

Zhang W

2014

Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome.

24560306

Gooding HC

2014

Diagnosing dysglycemia in adolescents with polycystic ovary syndrome.

24563180

Franik S

2014

Aromatase inhibitors for subfertile women with polycystic ovary syndrome.

24563672

Li X

2014

Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance.

24564914

Ortega-Hrepich C

2014

The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM.

24568043

Kashima K

2013

Polycystic ovary syndrome: association of a C/T single nucleotide polymorphism at tyrosine kinase domain of insulin receptor gene with pathogenesis among lean Japanese women.